Teva Announces Approval Of Generic Breast Cancer, Osteoporosis Drug Evista Tablets In The US

– Teva has 180 days of marketing exclusivity for generic Evista, which had 2013 US sales of $824 million. Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the approval from the US Food and More...